Clinical trial
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
NCT03403699 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 11, 2018
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.